Remedium Lifecare soars on receiving contract from pharmaceutical distribution company in UK
Remedium Lifecare is currently trading at Rs. 3.97, up by 0.18 points or 4.75% from its previous closing of Rs. 3.79 on the BSE.
The scrip opened at Rs. 3.97 and has touched a high and low of Rs. 3.97 and Rs. 3.87 respectively. So far 5000720 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 1 has touched a 52 week high of Rs. 38.25 on 26-Feb-2024 and a 52 week low of Rs. 3.65 on 14-Feb-2025.
Last one week high and low of the scrip stood at Rs. 3.97 and Rs. 3.65 respectively. The current market cap of the company is Rs. 160.07 crore.
The promoters holding in the company stood at 1.11%, while Non-Institutions held 98.89% stake in the company.
Remedium Lifecare has received a multi-year supply contract from a pharmaceutical distribution company based in the United Kingdom. This contract includes the supply of a range of Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals. The estimated value of the supplies scheduled from February 2025 to January 2026 alone is valued around Rs 182.70 crore.
Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.
